Shukra Pharmaceuticals Ltd — Updates, 30-05-2025: Company Update

Shukra Pharmaceuticals has announced a board meeting on 29 May 2025 to discuss the financial results for the quarter and half-year. The company reported total income from operations of ₹1,473.50 lakh for the quarter and ₹3,679.39 lakh for the year. Net profit after tax stood at ₹538.64 lakh for the quarter and ₹957.51 lakh for the year. Earnings per share were ₹0.42 (basic) for the quarter and ₹0.22 for the year. The results reflect steady profitability, supporting shareholder value with consistent operational performance.